Sophie Baratte
Vorstandsvorsitzender bei CELLNOVO
Aktive Positionen von Sophie Baratte
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CELLNOVO | Direktor/Vorstandsmitglied | 20.05.2016 | - |
| Vorstandsvorsitzender | 30.01.2016 | - | |
| Investor Relations Kontakt | 01.01.2014 | - | |
| Vorsitzender | 11.04.2016 | 09.06.2016 | |
| Corporate Officer/Principal | 01.01.2014 | - |
Karriereverlauf von Sophie Baratte
Ehemalige bekannte Positionen von Sophie Baratte
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| STENTYS | Direktor/Vorstandsmitglied | 21.03.2017 | 01.03.2021 |
| Independent Dir/Board Member | 21.03.2017 | 01.03.2021 | |
Cellnovo Ltd.
 Cellnovo Ltd. Medical SpecialtiesHealth Technology Cellnovo Ltd. manufactures diabetes management devices. The private company is based in Bridgend, UK. The British company was founded by Julian Shapley. The CEO is Sophie Baratte. | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | - | - |
Ausbildung von Sophie Baratte
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
| University of Compiègne | Doctorate Degree |
Statistik
International
| Frankreich | 5 |
| Vereinigtes Königreich | 2 |
Operativ
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Chairman | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Stentys SA
 Stentys SA Medical SpecialtiesHealth Technology Stentys SA engages in the design, development, and marketing of self-expanding stents used in treating cardiovascular diseases. It provides solutions for the treatment of acute myocardial infarction and other complex coronary diseases. Its products include Xposition S, Devoir, AmazoniaSir, stemiCath, Yangtzenano and YangtzeNC. The company was founded by Gonzague Issenmann and Jacques Seguin on July 6, 2006 and is headquartered in Neuilly-sur-Seine, France. | Health Technology |
Cellnovo Ltd.
Cellnovo Ltd. Medical SpecialtiesHealth Technology Cellnovo Ltd. manufactures diabetes management devices. The private company is based in Bridgend, UK. The British company was founded by Julian Shapley. The CEO is Sophie Baratte. | Health Technology |
Cellnovo Group SA
 Cellnovo Group SA Medical SpecialtiesHealth Technology Cellnovo Group SA was a medical technology company, which specialized in diabetes. The company developed and marketed the first mobile, connected, all-in-one diabetes management system that helps make life easier for patients. It products portfolio included system, switch, pump therapy, and patient stories. The company was founded by Julian Shapley on December 15, 2014 and was headquartered in Paris, France. | Health Technology |
- Börse
- Insiders
- Sophie Baratte
- Erfahrung
